Target intelligence / Profile preview

N-ethylmaleimide-sensitive factor (NSF)

Target
NSF
Molecular classification
Enzyme, AAA+ ATPase, Vesicular transport protein
01

Overview

N-ethylmaleimide-sensitive factor (NSF) is a highly conserved, homohexameric ATPase of the AAA+ (ATPases Associated with diverse cellular Activities) protein family, crucial for nearly all intracellular membrane trafficking events[1][3][5][7]. NSF acts by binding to and disassembling SNARE (soluble NSF attachment protein receptor) complexes after vesicle and target membrane fusion, a process key for recycling SNARE components and maintaining membrane trafficking throughout the cell[1][3][5][6][7]. NSF uses ATP hydrolysis to generate the mechanical force necessary for SNARE complex disassembly. Functional deficiency or mutation of NSF impairs vesicle fusion events and is implicated in several diseases, especially affecting neuronal function, given its essential role in neurotransmitter release and synaptic plasticity[5][7]. There are currently no drugs in clinical use specifically targeting NSF, primarily due to the protein’s ubiquitous and essential cellular roles, making it a challenging and risky therapeutic target.

Other names
N-ethylmaleimide sensitive fusion proteinNEM-sensitive factorNSF protein
02

Mechanism of action

Inhibition of ATPase activity blocks SNARE complex disassembly and vesicle trafficking

03

Biological functions

Intracellular membrane traffickingSNARE complex disassemblyMembrane fusionVesicle-mediated transport
04

Disease associations

Neurodegenerative diseaseNeurodevelopmental disordersOther
05

Safety considerations

Targeting NSF could disrupt essential vesicle trafficking, leading to broad cellular dysfunction
06

Interacting drugs

None clinically approved or in late-stage development; interacts with N-ethylmaleimide (research tool inhibitor)
07

Biomarkers

None established for patient selection or monitoring

Beyond the preview

Go deeper on N-ethylmaleimide-sensitive factor (NSF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-ethylmaleimide-sensitive factor (NSF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call